Abstract
Survivin is a protein which functions as a mitotic regulator as well as apoptosis inhibitor. In this study, we show that introduction of synthetic miR-542-3p mimetic reduced both mRNA and protein levels of survivin. In A549 cells, luciferase reporter assay revealed that miR-542-3p targeted predicted binding sites in the 3'-untranslated region (3'-UTR) of survivin. We also demonstrate that ectopic expression of miR-542-3p inhibited cell proliferation by inducing Gap 1 (G1) and Gap 2/Mitosis (G2/M) cell cycle arrest. Collectively, these results suggest that survivin is a direct target of miR-542-3p and growth inhibition by miR-542-3p may have a potential utility as an anti-cancer therapy.
Original language | English |
---|---|
Pages (from-to) | 4048-4052 |
Number of pages | 5 |
Journal | FEBS Letters |
Volume | 584 |
Issue number | 18 |
DOIs | |
Publication status | Published - Sept 2010 |
Bibliographical note
Funding Information:This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government (MEST) (No. 2009-0075381 ).
Keywords
- 18S ribosomal RNA
- Cell cycle arrest
- MiR-542-3p
- MicroRNA
- Survivin